Hologic (HOLX) Reports In-Line Q4 EPS; Guides Q1 Modestly Below Views

Hologic (NASDAQ: HOLX) reported Q4 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $813.5 million versus the consensus estimate of $806.55 million.

GUIDANCE:

Hologic sees Q1 2019 EPS of $0.55-$0.57, versus the consensus of $0.58. Hologic sees Q1 2019 revenue of $800-815 million, versus the consensus of $817.51 million.

Hologic sees FY2019 EPS of $2.38-$2.42, versus the consensus of $2.42. Hologic sees FY2019 revenue of $3.29-3.335 billion, versus the consensus of $3.31 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Hologic recalls BioZorb markers after reported injuries - FDA
• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance